These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36561250)

  • 1. Side Effects after mRNA COVID-19 Vaccine as a Booster in Health Workers.
    Pakki TR; Mariana N; Tampubolon ML; Rusli A; Romadhona S; Intan AD; Chohan Z; Widiantari AD; Herlina H; Puspitasari A; Mahardika M; Suliati S; Maemun S; Murtiani F; Syahril M
    Iran J Public Health; 2022 Nov; 51(11):2504-2509. PubMed ID: 36561250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
    Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
    Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Adverse Effects Immediately after the Start of COVID-19 Booster Vaccination in Vietnam.
    Nguyen DC; Dao TL; Truong TMD; Nguyen TH; Phan TN; Nguyen HM; Pham TD; Nguyen XB; Nguyen TB; Hoang VT
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of COVID-19 booster shot among healthcare workers: A mediation analysis approach.
    Rehman S; Rehman E; Jianglin Z
    Front Public Health; 2022; 10():1033473. PubMed ID: 36276365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel.
    Hidayat R; Mustika AP; Avisha F; Djuliannisaa Z; Winari DD; Putri RA; Lisman HM; Davin V; Widhani A; Aini MH; Rahmadani M; Istanti ND; Giantini A
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study.
    Ali MD; Almadan LZ; Alghamdi RA; Alghamdi AS; Almarhoon SA; Hassan YAM; Ahmad A; Ghosn SA; Banu N; Eltrafi Z
    Infect Drug Resist; 2022; 15():4335-4346. PubMed ID: 35971558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
    Qin W; Zhang X; Wang Y; Pan F; Cheng K; Huang F; Song J; Su H
    Front Public Health; 2022; 10():943876. PubMed ID: 35979461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public Knowledge About COVID-19 Booster Vaccines in Pakistan: A Study Conducted in a Tertiary Care Hospital in Karachi.
    Khan M; Jabeen S; Khizer Ali S; Tofique MH; Shabbir MS; Baig R; Khalili MN; Kumar S; Khatri M; Varrassi G; Sapna F; Dass A; Kumar N
    Cureus; 2023 Jun; 15(6):e40284. PubMed ID: 37448436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of COVID-19 Booster Dose among Saudi Arabian Population.
    Alshahrani NZ; Alsabaani AA; Ridda I; Rashid H; Alzahrani F; Almutairi TH; Alzahrani BAS; Albeshri ASS
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888690
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
    Kitro A; Sirikul W; Thongkum W; Soponpong S; Yasamut U; Kiratipaisarl W; Kosai A; Kasinrerk W; Tayapiwatana C; Srithanaviboonchai K
    Vaccine; 2022 May; 40(21):2915-2924. PubMed ID: 35430106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine.
    Rzymski P; Sikora D; Zeyland J; Poniedziałek B; Kiedik D; Falfushynska H; Fal A
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?
    Geers AL; Clemens KS; Colagiuri B; Jason E; Colloca L; Webster R; Vase L; Seig M; Faasse K
    Ann Behav Med; 2022 Aug; 56(8):761-768. PubMed ID: 35640203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
    Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions and Experiences of COVID-19 Vaccine Side-Effects Among Healthcare Workers in Southern Ethiopia: A Cross-Sectional Study.
    Zewude B; Habtegiorgis T; Hizkeal A; Dela T; Siraw G
    Pragmat Obs Res; 2021; 12():131-145. PubMed ID: 34938142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2022 May; 118():116-118. PubMed ID: 35192955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.